Category: Forbes

Can Aparito’s Wearable Tech Solve Big Pharma’s Billion-Dollar Crisis?

As many as 42% of pediatric clinical trials end up in failure and inconclusive results. This isn’t just a problem for the big pharma companies who are spending billions of dollars developing successful studies. It’s a problem for you, as we all pays a mark up on medication to cover these costs.

Unbeaten At Trial, Bayer and Janssen Say Cycle Of Xarelto Lawsuits ‘Needs To Be Stopped’

Early returns haven’t been positive for plaintiffs attorneys, so Xarelto liability theories have been mutating, defense says

Fitbit Launches An Activity Tracker For Kids — A Move That’s Smarter Than You Think

An activity tracker for kids just might be the ideal entry point for a lifetime of healthy habits.

Doctors Rip Trump DOJ’s Move To Gut Obamacare’s Patient Protections

At the American Medical Association meeting this week, doctors are discussing numerous ways to protect patients and upset at the Trump Justice Department’s move to gut Obamacare’s guaranteed issue rules.

Toddlers, You Are Eating Too Much Added Sugar, Study Suggests

A study presented yesterday at Nutrition 2018 showed how much added sugar Americans are feeding their infants and toddlers.

The ‘Right To Try Act’: Another Compliance Requirement For Pharma And Biotech Companies

Regardless of any lingering controversy, pharmaceutical and biotechnology companies will need to start preparing for the compliance requirements that this new legislation brings.

New $100 Genetic Test Identifies Men Who Have Vastly Increased Chance Of Developing Prostate Cancer

A new saliva-based test for prostate cancer can identify men at increased risk of developing the disease at a cost of less than $100.

A Story Of Devastation And Rebirth: The Former Pfizer Research Labs In Ann Arbor

The University of Michigan has provided a blueprint for how to take a difficult situation and convert it into a terrific growth story.

Month Six Of My DNA Diet Experiment With Arivale

Here’s how my yearlong DNA diet hacking is going.

Wuxi Biologics To Open U.S. Plant Amid Tough Trade Talk

Investment may involve $60 million